Removal of Erwinase (crisantaspase) supply constraints in the United Kingdom
05 Aug 2021 //
PRESS RELEASE
Porton Biologics Announces Closing Series-A Financing to Drive Production
19 Apr 2021 //
PRNASIA
Porton Biopharma signs potential $24m deal, push its intranasal anthrax vaccine
22 Oct 2019 //
PHARMAFILE